CRISPR Clinical Trials: A 2021 Update - Innovative Genomics Institute (IGI)
CRISPR Therapeutics: A Review Of Its Clinical Pipeline And Progress (NASDAQ:CRSP) | Seeking Alpha
CRISPR Clinical Trials to Watch for in 2022 and Beyond
CRISPR Clinical Trials: A 2021 Update - Innovative Genomics Institute (IGI)
News: CRISPR Therapy Turns a Corner With First Cures In Sight - CRISPR Medicine
CRISPR-Cas9 Clinical Trials as of February 2018. | Download Table
CRISPR Therapeutics and Vertex Announce New Clinical Data
CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases - ScienceDirect
Current clinical trials in hematology using the CRISPR/Cas9 system. | Download Scientific Diagram
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia | NEJM
Clinical trials of gene-editing therapies based on CRISPR/Cas9 technology. | Download Scientific Diagram
CRISPR Therapeutics (@CRISPRTX) / Twitter
Therapeutic gene editing with CRISPR/ Cas9 in clinical trials. | Download Table
CRISPR Therapeutics on Twitter: "Today, @CRISPRTX and @ViaCyte announced that the first patient has been dosed in the Phase 1 clinical trial of VCTX210 for the treatment of type 1 diabetes (T1D).
How CRISPR Is Changing Cancer Research and Treatment - NCI
crsp-ex991_7.htm
What's new in clinical CRISPR? | Nature Medicine
The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy - ScienceDirect
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis | NEJM
Phase I/II clinical trials that use CRISPR/Cas9 genome-editing technologies | Download Scientific Diagram
Intellia's early CRISPR trial data validate a drug pipeline and the gene-editing field - MedCity News